Follow-up of children with ARFID

Long-term follow-up of children with ARFID with and without treatment; a prospective study - Follow-up of children with ARFID

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON61276

Enrollment

300

Registered

2026-06-09

Start date

2024-03-01

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ARFID (avoidant/restrictive food intake disorder) ARFID

Interventions

Although the study is not designed to evaluate the effectiveness of treatment itself, treatment outcomes may be an important factor influencing the children's longer-term course and will therefore be

Eligibility

Age

2 Years to 17 Years

Inclusion criteria

Inclusion criteria: child 2-18 yearsdiagnosed with ARFIDreferred to SeysCentra for treatment

Exclusion criteria

Exclusion criteria: incomplete data

Design outcomes

Primary

Measure	Time frame
PARDI score (severity of ARFID symptoms)	—

Secondary

Measure	Time frame
Demographic characteristics (sex, age, weight, height, and parental educational level)Information on allied healthcare services received, nutritional supplementation, vitamin deficiencies, and the type and duration of treatment	—

Countries

Netherlands

Contacts

Public ContactRME Nowacki

Maastricht Universitair Medisch Centrum +

relana.nowacki@mumc.nl0433875284

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jun 29, 2026